Navigation Links
Cutting-edge amfAR grants fight HIV/AIDS in the lab and on the phone
Date:2/27/2009

NEW YORK, February 27, 2009 Most parents of teenage children have experienced frustration at their sons' and daughters' obsession with text messaging. But what if this ubiquitous technology could be used to save lives? At the University of Dar es Salaam in the East African nation of Tanzania, a country where few have landlines but most own a cell phone, that is precisely what Dr. Joyce Nyoni is trying to do.

amfAR, The Foundation for AIDS Research, today announced that it will fund three projects, including the work of Dr. Nyoni, that are harnessing social networking technologies to prevent the spread of HIV infection. Dr. Nyoni will recruit a small number of men who have sex with men (MSM), who in turn will recruit other MSM, to receive and send regular text messages containing HIV/AIDS information. At the end of her study, Dr. Nyoni will assess the changes in knowledge and behavior that she hopes will result from the program.

In addition to searching for novel ways to prevent HIV infection, at the other end of the research spectrum amfAR announced the award of six new grants for innovative biomedical research studies aimed at advancing the treatment and cure of HIV/AIDS.

On the 200th anniversary of Charles Darwin's birth, it is fitting perhaps that one of the grantees will use our deepening understanding of evolution to identify new targets for anti-HIV drugs. Dr. Sara Sawyer of the University of Texas at Austin will base her study on the Red Queen hypothesis, which suggests that organisms must continue to evolve just to keep up with the other organisms that surround them. Arguing that mutations in cell proteins that compromise HIV's ability to grow will be favored over time, Dr. Sawyer hopes to identify those that show the greatest promise as drug targets.

A third group of awards is allocated specifically to younger scientists who often have the greatest difficulty finding support for their work but who represent t
'/>"/>

Contact: Jennifer Samuels
jennifer.samuels@amfar.org
212-806-1756
amfAR, The Foundation for AIDS Research
Source:Eurekalert

Page: 1 2 3 4 5 6 7 8

Related biology news :

1. New edition of laboratory manual includes cutting-edge techniques to study gene regulation
2. Resilience in an aging society: GSA showcases cutting-edge meeting topics
3. Michael J. Fox Foundation Funds $1.1 Million for Cutting-edge Approaches to Parkinsons Disease
4. UW launches cutting-edge DNA fin-printing project for salmon
5. $10 million gift to support cutting-edge epigenome center at USC
6. Using green chemistry to deliver cutting-edge drugs
7. Texas Medical Center researchers win collaborative grants
8. NIH grants Phylonix Phase II SBIR to develop high-throughput in vivo zebrafish assays
9. Life Sciences Discovery Fund awards health research program grants
10. REGiMMUNE receives $12 million in grants to develop transplant and allergy drugs
11. NIST awards $24M in grants for new research facilities

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...ousands of years it has been prescribed by traditi...s from headaches and stomach pain to fever and flu...tle University have been able to scientifically pr...ta otherwise known as Brazilian mint. , Testing...m led by researcher Graciela Rocha was able to sho...
(Date:11/24/2009)... that keep weakened and flabby arteries from colla...nths, those stents are no longer needed -- once th...ry. Previously, doctors had no choice but to leave...Aviv University,s Department of Biomedical Enginee...form that carries drugs where they,re needed, then...
(Date:11/24/2009)...N ROUGE Antarctica has long held secrets of the e... recently, there has been very little information ...miles of ice for millions of years. Now, a team of... have been funded to the tune of $10 million doll... get to the bottom of things literally. These sci...
Breaking Biology News(10 mins):Got a pain? -- Have a cup of Brazilian mint 2A coating for life 2LSU gets to the bottom of things -- in Antarctica 2Virtify Inc Delivers Industrys First Enterprise Content Compliance Software Suite for Life Sciences Companies 12722 1Virtify Inc Delivers Industrys First Enterprise Content Compliance Software Suite for Life Sciences Companies 12722 2Virtify Inc Delivers Industrys First Enterprise Content Compliance Software Suite for Life Sciences Companies 12722 3Virtify Inc Delivers Industrys First Enterprise Content Compliance Software Suite for Life Sciences Companies 12722 4Virtify Inc Delivers Industrys First Enterprise Content Compliance Software Suite for Life Sciences Companies 12722 5Iran Blocks Access to the Chopra Center 26apos 3Bs Web Site Podcasts and Blogs 49586 1Iran Blocks Access to the Chopra Center 26apos 3Bs Web Site Podcasts and Blogs 49586 2Iran Blocks Access to the Chopra Center 26apos 3Bs Web Site Podcasts and Blogs 49586 3China Pharma Holdings Inc Announces SFDA Approval for Rosuvastatin Clinical Trials 49581 1China Pharma Holdings Inc Announces SFDA Approval for Rosuvastatin Clinical Trials 49581 2China Pharma Holdings Inc Announces SFDA Approval for Rosuvastatin Clinical Trials 49581 3
...n a mud flat at the edge of the Cocheco River, jus...ersity of New Hampshire,s Contaminated Sediments C...ted sediment in coastal waterways. , Rather than ...al feet of sand, they,ve created a patch black ge...ion in place. Over the next two years, UNH associa...
... is available in German . , Infectious proteins... of "mad cow" disease (BSE). The culprits are "inc...y proteins. The molecular bases for such prion dis...roteins infectious while others are not? A team he...aimon Sabat (University of Bordeaux, France) has e...
...f., June 16 Authernative, Inc., a,leading develop...management,technologies, announced today that it h...n (GSA) Information Technology Schedule contract, ...tive to sell its AuthGuard(R),user authentication ... Schedule contract, which represents Authernative,...
Other Biology News:UNH researchers test sediment-scrubbing technology in NH river 2UNH researchers test sediment-scrubbing technology in NH river 3Tracking prions 2Authernative Awarded GSA Schedule Contract 2Authernative Awarded GSA Schedule Contract 3
(Date:11/24/2009)...w York investment bank KTA Capital,s client Neuren...7 mil convertible note private placement with a U....as arranged by KTA Capital as Neuren,s exclusive p... New York (PRWEB) November 23, 2009 -- The ind... ("KTA Capital") has announced that its ...
(Date:11/24/2009)...re-FirstCall/--Sigma-AldrichCorporation(Nasdaq: SI...day,December1stat1:45PMGMTinLondon,7:45AMUS/CST.In...heInternetavailableat http://inve s tor.sig m ...toaccessthisfile. ,, AboutSigma-Aldrich: Sig...mpany.Itschemicalandbiochemicalproductsandkitsareu...
(Date:11/24/2009)...RNewswire-FirstCall/--NeurogesX,Inc.(Nasdaq: NGSX ...ommercializingnovelpainmanagementtherapies,announc...veOfficer,isscheduledtopresentatthe21stAnnualPiper...09atTheNewYorkPalaceHotelinNewYork,NewYork. ,, ...r,willbeavailabletorespondtoquestionsduringthepres...
(Date:11/24/2009)...asbeenmetforpatientswithadvanced-stage,orrecurrent...wire-FirstCall/-AEternaZentarisInc.(NASDAQ: AEZS ;...panyfocusedonendocrinetherapyandoncology,todayanno...rgetedcytotoxicpeptideconjugate,AEZS-108(formerlyA...lcancer.Inapersonalizedhealthcareapproach,thestudy...
Breaking Biology Technology:KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4
...TON, July 29 Scimitar Equity, LLC issues a review...ard: VOQP), entitled, "510k,Application Submitted ...cta(TM) Focuses Milestones and Share Price Appreci...tp://www.scimitarequity.com ., VioQuest Pharmaceu...,dedicated to becoming a recognized leader in the ...
... CARLOS, Calif., July 29 Nuvelo, Inc.,(Nasdaq: N...st subject in a,single-center, Phase 1 trial of re...lead compound from its Wnt Therapeutics Program. T...ding dose (SAD) trial will,determine the safety, t...ous (IV) administration of NU206, in approximately...
... "As one of AFRA,s fou...ceive its accreditation," remarks Gregoire Le... "For more than 10 years our vision in the gl...n, JMV Aviation and BAR) has been to operate in a ... to our five locations in France as well as facili...
Other Biology Technology:VioQuest Pharmaceuticals, Inc Valuation Upgrade Review Issued By Scimitar Equity, LLC 2Nuvelo Initiates Phase 1 Clinical Trial of NU206 in Healthy Volunteers 2Nuvelo Initiates Phase 1 Clinical Trial of NU206 in Healthy Volunteers 3First Program Addressing Aircraft Industry Sustainability Awards Accreditation To Five Global Companies 2First Program Addressing Aircraft Industry Sustainability Awards Accreditation To Five Global Companies 3First Program Addressing Aircraft Industry Sustainability Awards Accreditation To Five Global Companies 4
RDF (R106-05) from European Collection of Cell Cultures (ECACC)
...The Brownlee Precision Model 440 incorporates four...rcuitry in a friendly easy-to-use instrument. Each...er, an 8-pole Bessel lowpass filter, a highpass fi...ols. A control knob sets the amplifier parameters ...
REK (R102-05) from European Collection of Cell Cultures (ECACC)
PCAEC (P300-05) from European Collection of Cell Cultures (ECACC)
Biology Products: